1,10-phenanthroline has been researched along with Experimental Neoplasms in 2 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wesselinova, D | 1 |
| Neykov, M | 1 |
| Kaloyanov, N | 1 |
| Toshkova, R | 1 |
| Dimitrov, G | 1 |
| Rebeiz, N | 1 |
| Arkins, S | 1 |
| Rebeiz, CA | 1 |
| Simon, J | 1 |
| Zachary, JF | 1 |
| Kelley, KW | 1 |
2 other studies available for 1,10-phenanthroline and Experimental Neoplasms
| Article | Year |
|---|---|
Antitumour activity of novel 1,10-phenanthroline and 5-amino-1,10-phenanthroline derivatives.
Topics: Amination; Animals; Antineoplastic Agents; Cricetinae; Dose-Response Relationship, Drug; Drug Screen | 2009 |
Induction of tumor necrosis by delta-aminolevulinic acid and 1,10-phenanthroline photodynamic therapy.
Topics: Aminolevulinic Acid; Animals; Drug Interactions; Drug Screening Assays, Antitumor; Female; Humans; M | 1996 |